Our platform is open, use as much or as little as you need.
Whether you are developing your own assay or want us to deliver one for you.
VH-Platform
Vidiia Hunter: The Molecular Development Platform Built for Point-of-Care from Day One
Develop here. Deploy anywhere.
You are an assay developer, R+D scientist, or molecular biology researcher with a target that has point-of-care or field-deployable ambitions. You want to iterate faster and cheaper than PCR, in an open development environment that does not lock you into a lab.
Vidiia’s Hunter Platform, is the only platform where the device you develop on is the device you deploy on.
No translation layer. No revalidation. No compromise.
If you are developing or adapting a molecular assay and want a platform that is deployable from day one, the Vidiia Hunter is built for you.
Co-Lab/Custom
Assay Collaboration, Scientific Partnerships and Custom Components
If you have a commercial target and need a partner to take it from research to a validated, field-deployable molecular diagnostic, we offer three ways to work together.
Full Collaboration End-to-end development, from assay design through to a validated, submission-ready package. You hold the regulatory pathway and take the product to market.
Scientific Partnership We work inside your existing programme, contributing molecular diagnostic expertise without disrupting your workflows or IP ownership. You retain full control of the regulatory pathway.
Custom Components We develop tailored versions of our platform components, including VH-RapidPrep and VH-LyoMM, for integration into your assay, platform, or test kit. Built to your specification, validated to ours.
Talk to our experts
No task is too small, or too ambitious. We are here to help.